Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dichotomous Tests Thomas B. Newman, MD, MPH September 27, 2012 Thanks to Josh Galanter and Michael Shlipak 1.

Similar presentations


Presentation on theme: "Dichotomous Tests Thomas B. Newman, MD, MPH September 27, 2012 Thanks to Josh Galanter and Michael Shlipak 1."— Presentation transcript:

1 Dichotomous Tests Thomas B. Newman, MD, MPH September 27, 2012 Thanks to Josh Galanter and Michael Shlipak 1

2 Overview n Clarifications, chapter 1, chapter 2 material n Definitions: sensitivity, specificity, prior and posterior probability, predictive value, accuracy n 2 x 2 table method n Likelihood ratios - WOWO n Probability and odds n FP/FN confusion n Test/treat thresholds 2

3 Clarifications n EBD errata on book website n SLUBI= Self limited undiagnosed benign illness – not a term I use with parents 3

4 Definitions: Sensitivity and Specificity 4 Disease status Has diseas e No disease Total Test Resul t PositiveABA + B NegativeCDC + D TotalA + CB + DA + B + C + D Sensitivity = A/ (A+C) Specificity = D/ (B+D) P.I.D. = Positive in Disease N.I.H.= Negative in Health

5 Definitions: Positive and Negative Predictive value, Accuracy 5 Disease status Has diseas e No disease Total Test Resul t PositiveABA + B NegativeCDC + D TotalA + CB + DA + B + C + D PPV=A/(A+B) NPV=D/(C+D) n Accuracy = (A + D)/(A + B + C + D) n = (A+D)/N n Accuracy demonstration: screening for brain tumors

6 Definitions: Pretest (prior) and post-test (posterior) probability 6 Disease status Has diseas e No disease Total Test Resul t PositiveABA + B NegativeCDC + D TotalA + CB + DA + B + C + D Pretest probability = ONLY IF SAMPLING IS “CROSS-SECTIONAL”! (A+C)/(A+B+C+D) Posttest probability =A/(A+B) or C/(C+D)

7 “Cross-sectional” sampling 7 Disease status Has diseas e No disease Total Test Resul t PositiveABA + B NegativeCDC + D TotalA + CB + DA + B + C + D PPV=A/(A+B) NPV=D/(C+D) n Subjects are sampled randomly or consecutively, so that the proportion with disease (pretest probability, prevalence) is clinically meaningful

8 “Case-control” sampling 8 Disease status Has diseas e No disease Total Test Resul t PositiveABA + B NegativeCDC + D TotalA + CB + DA + B + C + D PPV=A/(A+B) NPV=D/(C+D) n Subjects with and without disease are sampled separately n Proportion with disease is determined by investigator Disease status Has diseas e No disease Total Test Resul t PositiveABA + B NegativeCDC + D TotalA + CB + DA + B + C + D

9 Prevalence vs Pretest probability n Pretest probability is the more general term n For screening tests, pretest probability = prevalence n For diagnostic tests, pretest probability incorporates history and physical exam items 9

10 Post-test probability vs. Predictive value n Posttest probability after a + test is the same as positive predictive value n Posttest probability after a – test is 1– negative predictive value 10

11 2  2 Table Method n Research vignette “Tom, you need to call this mother. She’s really upset.” 11

12 Choroid Plexus Cyst 12

13 Fill in table 13 Pretest probability 0.0003 Sensitivity 33% n Specificity 98.5% Disease status Trisomy 18 No Trisomy 18 Total Choroid Plexus Cyst Present Absent Total

14 Likelihood Ratios 14

15 Likelihood ratios n A ratio of likelihoods: P(Result|Disease) P(Result|No Disease) n WOWO = With Over WithOut n Pretest odds x LR = Posttest odds n (Prior odds x LR = Posterior odds) 15

16 What Tests Do Their results change the probability of disease Negative testPositive test Reasurance Treatment Order a Test A good test moves us across action thresholds. 0%100% HIV+HIV- 16

17 Likelihood of Disease Depends on 2 Things 1. Where you started from (low, medium, high risk) 2. Length and direction of the “arrow” n Basic paradigm: –What we thought before  test result  what we think now 17

18 Likelihood ratioEffect of test result Very small (0.01)Greatly decreases P(disease) Less than 1 (0.5)Decreases P(disease) OneNo effect on P(disease) More than 1 (2)Increases P(disease) Very big (100)Greatly increases P(disease) 18

19 Likelihood Ratios n Advantages – Calculation of post-test probability easier (especially when disease is rare) –Capture information for multi-level and continuous tests (next week) n Disadvantages –If either pretest or posttest probability is high (~> 10%) you need to use odds (or a slide rule or calculator) 19

20 Switch to board n LR for the choroid plexus cyst example –Dichotomous test def of LR n Probability and odds 20

21 Can Use Slide Rule 21

22 False-negative confusion n Sensitivity of rapid strep test is 85% n Therefore, false negative rate is 15% n 15% is too high, so always culture to confirm negative rapid strep tests 22

23 What’s wrong? StrepNo StrepTotal Rapid Test + TPFPTP+FP Rapid Test - FNTNTN+FN TP+FNFP+TN n 2 definitions of “false negative rate” –Def #1: 1-sensitivity = FN/(TP+FN). This one is easier because it’s (assumed to be) constant. –Def #2: 1 - negative predictive value = FN/(FN+TN). This one is harder because it depends on prior probability, but it is the one that should determine clinical decisions. 23

24 If prior probability of strep = 20% and specificity is 98% n False negative rate (def #2) = 15/407 = 3.7% n NNC (number needed to culture) = 1/.037 = 27 to identify 1 false negative rapid test. (Pre-test probability of 20%) n At some prior probability of strep, culture after negative quick test is not indicated. 24

25 25 n Sensitivity 85% n Specificity 98% n Prior probability = 20% n Rapid test is NEGATIVE n LR = Try it with slide rule!

26 Similar examples: n Sensitivity of UA for UTI is only 80%, therefore always culture after a negative UA n Sensitivity of CT scan for subarachnoid hemorrhage is only 90%, therefore always do LP after a negative CT n False positive confusion is similar: 1- specificity vs. 1-positive predictive value 26

27 Test/Treat Thresholds No test Treat Test 27

28 “X-Graph” 28

29 New “X-Graph” 29

30 Questions? 30


Download ppt "Dichotomous Tests Thomas B. Newman, MD, MPH September 27, 2012 Thanks to Josh Galanter and Michael Shlipak 1."

Similar presentations


Ads by Google